Atara Biotherapeutics (ATRA) vs Neumora Therapeutics (NMRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Atara Biotherapeutics (ATRA) has outperformed Neumora Therapeutics (NMRA) over the past year, losing 40.1% versus a loss of 74.8%. Atara Biotherapeutics is the larger company by market cap ($92.1 million vs $88.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRA | NMRA |
|---|---|---|
| Share price | $9.18 | $0.472 |
| Market cap | $92.15M | $88.69M |
| 1-day change | -2.03% | +0.79% |
| YTD return | -48.20% | -73.84% |
| 1-year return | -40.05% | -74.82% |
| 5-year return | -97.52% | — |
| Forward P/E | 5.94 | — |
| EPS (TTM) | $-1.30 | $-1.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.15 | $3.65 |
| 52-week low | $3.92 | $0.451 |
| Distance from 52-week high | -52.05% | -87.07% |
| Average volume | 54.11K | 1.18M |
| Shares outstanding | 10.04M | 187.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATRA has outperformed NMRA by 34.8 percentage points over the past year.
ATRA vs NMRA FAQ
Which is bigger, Atara Biotherapeutics or Neumora Therapeutics?
Atara Biotherapeutics (ATRA) is larger, with a market capitalization of $92.15M compared with $88.69M for Neumora Therapeutics (NMRA).
Which stock has performed better over the past year, ATRA or NMRA?
ATRA returned -40.05% over the past 12 months, compared with -74.82% for NMRA (price return, excluding dividends). Past performance does not predict future results.
Are Atara Biotherapeutics and Neumora Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.